-
Amazon Deals - ToS - Warp
COVID-19
- Thread starter Sushubh
- Start date
- Replies 3,747
- Views 231,542
one article I read about corona viruses research not specfically covid-19, it says immunity only last 2-3 months. You will need vaccines every 6 months.
Coronavirus antibodies may last only two to three months after infection, study suggests
Within eight weeks, 81% of the asymptomatic people saw a reduction in neutralizing antibodies compared with 62% of symptomatic patients.
Not looking good, 180k new cases
Almost 15k cases in india
55k cases in Brazil
There seems to be 2 inflection points, an inflection point signifies a turn of events(i.e. going towards more or less infections)
Inflection point 1 was the good news, if everything went like that we would have been in pretty good condition
But point 2 happened signifying a return of growth of cases which should have been the alarming point
To know whether we are moving towards a growth or a die out of coronavirus we need to find where the direction of curvature changes(known as point of inflection) and not the point where change in direction of the slope occurs
Inflection point 1 was the good news, if everything went like that we would have been in pretty good condition
But point 2 happened signifying a return of growth of cases which should have been the alarming point
To know whether we are moving towards a growth or a die out of coronavirus we need to find where the direction of curvature changes(known as point of inflection) and not the point where change in direction of the slope occurs
Last edited:
D
Deleted member 13033
Lol, oops I did not consider this
vaccines are under development maybe under 1 year it will distributed after trial. Vaccination from oxford med university are already under production and waiting for approval, beyond which it may or may not be given to general population.
Then there is news such as a second wave or mutated corona -or super spreader corona being found in china.
Coronavirus Outbreak: Beijing COVID-19 cases plunge Chinese Super League into fresh doubt-Sports News , Firstpost
An outbreak of the coronavirus in Beijing has further “complicated” plans to start the postponed Chinese Super League (CSL), a medical expert advising the country’s soccer association said.
www.firstpost.com
‘Covid drug’ favipiravir to be available at Rs 103/tablet by month-end
Favipiravir, an antiviral medication developed in Japan, is currently the subject of 18 trials around the world as a potential treatment for Covid-19.
theprint.in
Found from another article
Glenmark's FabiFlu approved for COVID-19 treatment in India; priced at Rs 103 a tablet
This comes out to ₹ 6,695.
I am pretty sure the government is not going to subsidise it.
It's worse.
Looks like the above article had a typo. Confirmed the following from two websites. lol
www.cnbctv18.com
www.livemint.com
According to me, the cost comes to ₹12, 566 but chalo ... nice round off till 14k.
Looks like the above article had a typo. Confirmed the following from two websites. lol
Glenmark launches Favipiravir for treatment of mild to moderate COVID-19 patients
Anti-viral drug Favipiravir approved for treatment of mild to moderate COVID-19 patients will be commercialised full scale in a week, says drug maker Glenmark Pharmaceuticals.
www.cnbctv18.com
Glenmark launches Favipiravir after encouraging results in clinical trials
Glenmark developed the active pharmaceutical ingredient (API) and the formulation for FabiFlu® through its own in-house R&D team
www.livemint.com
According to me, the cost comes to ₹12, 566 but chalo ... nice round off till 14k.
Chinese trial's issue: The limitation of this study was that it was not randomized double-blinded and placebo-controlled.
Russia also did their own trial but have approved mid-stage. Their trial was going to end around December.
Glenmark's trial in India - was supposed to finish in July/August. Approved early?
Itlay also started a trial but with a giant warning - that evidence in support of the drug is scant.
Only 1 hospital in the US is doing a small trial. Another one started in London.
Russia also did their own trial but have approved mid-stage. Their trial was going to end around December.
Glenmark's trial in India - was supposed to finish in July/August. Approved early?
Itlay also started a trial but with a giant warning - that evidence in support of the drug is scant.
Only 1 hospital in the US is doing a small trial. Another one started in London.
